65,437 trials
Postmenopausal Osteoporosis
Primary: Cortical Thickness of Radius by XtremeCT Percent Change From Baseline at Month 12 — 2.4; 3.4; -.8 Percent Change from Baseline
Diabetes Mellitus
Primary: Number of Subjects With Decline in Forced Expiratory Volume (FEV1) Exceeding 20% From Baseline — 100; 112; 81; 105 participants
Hysterectomy · Postoperative
Primary: Sum of Pain Intensity Differences Relative to the Baseline Pain Intensity. — 48.8; 49.0; 52.4; 52.9 units on scale — p=<0.0001
Rheumatoid Arthritis
Primary: Percentage of Participants Meeting the Criteria of the American College of Rheumatology for 20% Improvement (ACR20) — 65.5; 42.1 percentage of participants
Postmenopausal Osteoporosis
Primary: Lumbar Spine Bone Mineral Density Percent Change From Baseline at Month 24 — 6.5; -.6 Percent Change from Baseline — p=<0.0001
Hypertension
Primary: Percentage of Patients Achieving Blood Pressure (BP) Control — 66; 46; 65 Percentage of Participants
Post-Stroke Spasticity · Cerebrovascular Accident
Primary: Area Under the Curve (AUC) for the Change From Baseline in Modified Ashworth Scale (MAS) Ankle Score to the End of the DB Phase (Week 12) — -8.513; -5.085 Score*week…
Breast Cancer · Low Bone Mineral Density · Osteopenia
Primary: Lumbar Spine Bone Mineral Density Percent Change From Baseline at Month 12 — 4.8; -.7 Percent Change from Baseline — p=<0.0001
Hypercholesterolemia
Primary: Percent Change in Plasma Low Density Lipoprotein-cholesterol (LDL-C) From Day 1 (Study Baseline) to Week 8. — 2.9; -3.7; -10.6 percent change from baseline — p=0.1122
Parkinson Disease
Primary: Change From Baseline in the Blinded Rater Unified Parkinson's Disease Rating Scale (UPDRS) Total Score at Month 15 — 0.3; 0.7 Units on a scale — p=0.6503
Attention Deficit Hyperactivity Disorder
Primary: Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator Administered and Scored (ADHDRS-IV-Parent:Inv) Total Score at 12 Week Endpoint…
Multiple Sclerosis, Relapsing-Remitting
Primary: Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious AEs (SAEs) — 826; 487; 66; 161 participants
Glaucoma
Primary: Mean Intraocular Pressure (IOP) at 9 AM — 16.3; 18.1 millimeters mercury (mmHg)
Infection
Primary: Change in Mean Number of Skin Bacterial Counts From Baseline to 72 Hours — -1.91; -1.87 log 10 CFU/cm sq — p=<0.001
Acute Myocardial Infarction
Primary: High Mobility Group Box-1 (HMGB1)Levels at Baseline and 6 Months — 27.6; 24.5; 11.7; 20.5 ng/ml — p=<0.05